Literature DB >> 9656990

Suppression of antigen-specific T cell proliferation by measles virus infection: role of a soluble factor in suppression.

X Sun1, J B Burns, J M Howell, R S Fujinami.   

Abstract

Measles virus infection causes a profound immunosuppression. The basis for this immunosuppression is not known. This immunosuppression could be due to virus acting directly on lymphoid cells, the production of an immunosuppressive viral product, or a lymphoid product. We have developed an antigen-specific T cell system to study measles virus-T-cell interactions. We demonstrate that as few as five infectious viral particles added to 1000 T cells results in profound inhibition of antigen-specific T cell proliferation. Supernates taken from measles virus-infected T cells suppress the proliferation of uninfected T cells. Measles-virus-infected HeLa or Vero cells do not produce the factor. The antiproliferative effects of the supernates cannot be attributed to infectious virus, IL-10 or TGF-beta. The soluble factor appears to be larger than 100 kDa, yet retains antiproliferative activity following trypsin digestion with a size less than 10 kDa. Loss of activity is seen following heat treatment at 56 degrees C. The factor is lymphoid cell specific and exhibits cytokine-like behavior yet appears not to be a known cytokine. This soluble factor may be responsible for the overt clinical immunosuppression seen in man and a previously undescribed cytokine induced by measles virus infection of human lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9656990     DOI: 10.1006/viro.1998.9186

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Modulation of immune system function by measles virus infection: role of soluble factor and direct infection.

Authors:  R S Fujinami; X Sun; J M Howell; J C Jenkin; J B Burns
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

2.  Proteolytic cleavage of the fusion protein but not membrane fusion is required for measles virus-induced immunosuppression in vitro.

Authors:  A Weidmann; A Maisner; W Garten; M Seufert; V ter Meulen; S Schneider-Schaulies
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Measles virus-induced immunosuppression in vitro is independent of complex glycosylation of viral glycoproteins and of hemifusion.

Authors:  A Weidmann; C Fischer; S Ohgimoto; C Rüth; V ter Meulen; S Schneider-Schaulies
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 4.  Measles virus-induced immunosuppression: from effectors to mechanisms.

Authors:  Elita Avota; Evelyn Gassert; Sibylle Schneider-Schaulies
Journal:  Med Microbiol Immunol       Date:  2010-04-08       Impact factor: 3.402

5.  Does Zika virus infection induce prolonged remissions in children with idiopathic nephrotic syndrome?

Authors:  Carolina Peralta-Aros; Víctor García-Nieto
Journal:  Pediatr Nephrol       Date:  2017-02-07       Impact factor: 3.714

Review 6.  Measles virus interactions with cellular receptors: consequences for viral pathogenesis.

Authors:  J Schneider-Schaulies; V ter Meulen; S Schneider-Schaulies
Journal:  J Neurovirol       Date:  2001-10       Impact factor: 2.643

7.  Measles virus interacts with human SLAM receptor on dendritic cells to cause immunosuppression.

Authors:  Bumsuk Hahm; Nathalie Arbour; Michael B A Oldstone
Journal:  Virology       Date:  2004-06-01       Impact factor: 3.616

8.  Cytokine imbalance after measles virus infection has no correlation with immune suppression.

Authors:  Mary Carsillo; Kay Klapproth; Stefan Niewiesk
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

Review 9.  Making it to the synapse: measles virus spread in and among neurons.

Authors:  V A Young; G F Rall
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

10.  Clinical and immunological analysis of measles patients admitted to a Beijing hospital in 2014 during an outbreak in China.

Authors:  B Tu; J-J Zhao; Y Hu; J-L Fu; H-H Huang; Y-X Xie; X Zhang; L Shi; P Zhao; X-W Zhang; D Wu; Z Xu; Z-P Zhou; E-Q Qin; F-S Wang
Journal:  Epidemiol Infect       Date:  2016-06-02       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.